209 related articles for article (PubMed ID: 24068669)
21. Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.
Zeng H; Yu M; Tan H; Li Y; Su W; Shi H; Dhungana Y; Guy C; Neale G; Cloer C; Peng J; Wang D; Chi H
Sci Adv; 2018 Jan; 4(1):eaar5701. PubMed ID: 29399633
[TBL] [Abstract][Full Text] [Related]
22. c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells.
Wang QF; Lauring J; Schlissel MS
Mol Cell Biol; 2000 Dec; 20(24):9203-11. PubMed ID: 11094072
[TBL] [Abstract][Full Text] [Related]
23. Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia.
Wang C; Li L; Li M; Shen X; Liu Y; Wang S
Exp Cell Res; 2021 Jan; 398(1):112371. PubMed ID: 33188849
[TBL] [Abstract][Full Text] [Related]
24. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.
Geng CD; Vedeckis WV
J Biol Chem; 2005 Dec; 280(52):43264-71. PubMed ID: 16263717
[TBL] [Abstract][Full Text] [Related]
25. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
26. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.
Fernández de Mattos S; Essafi A; Soeiro I; Pietersen AM; Birkenkamp KU; Edwards CS; Martino A; Nelson BH; Francis JM; Jones MC; Brosens JJ; Coffer PJ; Lam EW
Mol Cell Biol; 2004 Nov; 24(22):10058-71. PubMed ID: 15509806
[TBL] [Abstract][Full Text] [Related]
27. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
[No Abstract] [Full Text] [Related]
28. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate.
Lin YC; Jhunjhunwala S; Benner C; Heinz S; Welinder E; Mansson R; Sigvardsson M; Hagman J; Espinoza CA; Dutkowski J; Ideker T; Glass CK; Murre C
Nat Immunol; 2010 Jul; 11(7):635-43. PubMed ID: 20543837
[TBL] [Abstract][Full Text] [Related]
29. RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.
Bednarski JJ; Pandey R; Schulte E; White LS; Chen BR; Sandoval GJ; Kohyama M; Haldar M; Nickless A; Trott A; Cheng G; Murphy KM; Bassing CH; Payton JE; Sleckman BP
J Exp Med; 2016 Feb; 213(2):209-23. PubMed ID: 26834154
[TBL] [Abstract][Full Text] [Related]
30. Fra-2 regulates B cell development by enhancing IRF4 and Foxo1 transcription.
Ubieta K; Garcia M; Grötsch B; Uebe S; Weber GF; Stein M; Ekici A; Schett G; Mielenz D; Bozec A
J Exp Med; 2017 Jul; 214(7):2059-2071. PubMed ID: 28566276
[TBL] [Abstract][Full Text] [Related]
31. c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB.
Postigo AA; Sheppard AM; Mucenski ML; Dean DC
EMBO J; 1997 Jul; 16(13):3924-34. PubMed ID: 9233802
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional repression of Gata3 is essential for early B cell commitment.
Banerjee A; Northrup D; Boukarabila H; Jacobsen SE; Allman D
Immunity; 2013 May; 38(5):930-42. PubMed ID: 23684985
[TBL] [Abstract][Full Text] [Related]
33. The survival and differentiation of pro-B and pre-B cells in the bone marrow is dependent on IL-7Rα Tyr449.
Patton DT; Plumb AW; Abraham N
J Immunol; 2014 Oct; 193(7):3446-55. PubMed ID: 25143441
[TBL] [Abstract][Full Text] [Related]
34. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
35. Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming.
Li R; Cauchy P; Ramamoorthy S; Boller S; Chavez L; Grosschedl R
Genes Dev; 2018 Jan; 32(2):96-111. PubMed ID: 29440261
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.
Welsh SJ; Churchman ML; Togni M; Mullighan CG; Hagman J
Leukemia; 2018 Jan; 32(1):38-48. PubMed ID: 28555080
[TBL] [Abstract][Full Text] [Related]
37. Establishment and maintenance of B cell identity.
Grosschedl R
Cold Spring Harb Symp Quant Biol; 2013; 78():23-30. PubMed ID: 24733381
[TBL] [Abstract][Full Text] [Related]
38. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development.
Malin S; McManus S; Cobaleda C; Novatchkova M; Delogu A; Bouillet P; Strasser A; Busslinger M
Nat Immunol; 2010 Feb; 11(2):171-9. PubMed ID: 19946273
[TBL] [Abstract][Full Text] [Related]
39. c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1+ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin.
Shikatani EA; Chandy M; Besla R; Li CC; Momen A; El-Mounayri O; Robbins CS; Husain M
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1367-76. PubMed ID: 27174098
[TBL] [Abstract][Full Text] [Related]
40. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.
Nicot C; Mahieux R; Pise-Masison C; Brady J; Gessain A; Yamaoka S; Franchini G
Mol Cell Biol; 2001 Nov; 21(21):7391-402. PubMed ID: 11585920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
